CAS: 74356-00-6; Cefotetan Disodium

该化合物是一种主要用于治疗各种细菌感染的广谱性脑膜结肠杆菌抗生素抗生素,对克氏阳性细菌和克氏阴性细菌有效,在临床环境中是一种宝贵的选择;该化合物的特点是二钠盐形式,它增加了溶液溶液的溶性,便利静脉静脉注射;Cefotetan通过抑制细菌细胞壁合成,导致细胞分解和死亡,进行工作;特别注意到它的活动是抗厌细菌,它有助于手术预防以及治疗腹部内感染;该物质通常通过注射进行,其药用皮肤皮肤皮肤部的药物包括相对短的半衰期,需要多剂量才能产生持续的治疗效果;常见的副作用可能包括胃肠扰动,过敏反应以及与其他药物的潜在相互作用;同所有抗生素一样,适当使用对于防止抗生素抗体抗体的发育至关重要;

结构式图片

欧盟法规

ECHA物质C&L通报REACH预注册

上下游产品

methyl>-Δ3-cephem-4-carboxylatediphenylmethyl (6R,7S)-7-amino-7-methoxy-3-(1-methyl-1H-tetrazol-5-yl)thiomethyl-Δ3-cephem-4-carboxylate

合成工艺路线路线简述

    📜在 苯甲醚,三氟乙酸,碳酸氢钠体系中,用 二氯甲烷,异丙醚,水作为反应溶剂,以93.2%的收率获得cefotetan Disodium
    参考文献:一种抗感染类头孢药物的制备方法
    标题:一种抗感染类头孢药物的制备方法
    摘要:本发明公开了一种抗感染类头孢药物的制备方法,本发明将7‑mac(ⅱ)与2‑氧代乙酸水合物反应制备化合物iii,化合物iii与2‑氨基甲酰基‑3,3‑二巯基丙烯酸进行缩硫醛化反应制备化合物iv,再经过脱保护,成盐制得头孢替坦二钠(I).本发明合成路线简单,反应条件温和,降低了杂质的生成,提高了产品总收率及纯度,适合工业化生产.

    海关参考信息

    专利信息


    专利号:US-8557979-B2
    优先权日:2004-06-10
    标题 :Carbapenem antibacterials with gram-negative activity and processes for their preparation
    发明人:CHOI WOO-BAEG; KOWALIK EWA
    权利人:CHOI WOO-BAEG; KOWALIK EWA; FOB SYNTHESIS INC
    摘要:The present invention provides β-methyl carbapenem compounds and pharmaceutical compositions useful in the treatment of bacterial infections and methods for treating such infections using such compounds and/or compositions. The invention includes administering an effective amount of a carbapenem compound or salt and/or prodrug thereof to a host in need of such a treatment. The present invention is also in the field of synthetic organic chemistry and is specifically provides an improved method of synthesis of β-methyl carbapenems which are useful as antibacterial agents.

    专利号:US-10933051-B2
    优先权日:2017-06-09
    标 题 :Carbapenem compounds and compositions for the treatment of bacterial infections
    发明人:CHOI WOO-BAEG; TOMIOKA TAKASHI; JOO HYUNG-YEUL; TRUONG PHONG; MIN BRIAN
    权利人:FOB SYNTHESIS INC
    摘要:The present invention provides carbapenem compounds and pharmaceutical compositions useful in the treatment of bacterial infections, including drug resistant or multiple-drug resistant bacterial infections, and methods for treating such infections using such compounds and/or compositions. The invention includes administering an effective amount of a carbapenem compound or salt and/or prodrug thereof to a host in need of such a treatment.

    专利号:US-9693999-B2
    优先权日:2011-01-26
    标题:Small molecule RNase inhibitors and methods of use
    发明人:DUNMAN PAUL M; OLSON PATRICK D; CHILDERS WAYNE
    权利人:UNIV ROCHESTER; UNIV NEBRASKA; Temple University—Of the Commonwealth System of Higher Education
    摘要:Small molecule inhibitors of bacterial ribonuclease (e.g., RnpA) and methods for their synthesis and use are described herein. The methods of using the compounds include treating and preventing microbial infections and inhibiting bacterial ribonuclease. Also described herein are methods of identifying compounds for treating or preventing a microbial infection.

    专利号:US-9937151-B2
    优先权日:2010-06-18
    标题 :Carbapenem antibacterials with gram-negative activity
    发明人:CHOI WOO-BAEG; GRUSZECKA-KOWALIK EWA; JOO HYUNG-YEUL; LIU SHUANGPEI; MAO SHULI; LI YONGFENG; KIM DEOG-IL
    权利人:FOB SYNTHESIS INC
    摘要:The present invention provides β-methyl carbapenem compounds and pharmaceutical compositions useful in the treatment of bacterial infections and methods for treating such infections using such compounds and/or compositions. The invention includes administering an effective amount of a carbapenem compound or salt and/or prodrug thereof to a host in need of such a treatment.

    专利号:WO-2009056955-A1
    优先权日:2007-10-30
    标题 :Amine-bearing phospholipids (abps), their synthesis and use
    发明人:ZUMBUEHL ANDREAS
    权利人:UNIV BASEL; ZUMBUEHL ANDREAS
    摘要:Disclosed herein are amine-bearing phospholipids (ABP). The ABPs display many properties and functionalities of naturally occurring phospholipids, but also new properties and functionalities, such as the ability to polymerize while maintaining structural integrity, that may supplement or expand the functionalities of naturally occurring phospholipids.

    专利号:US-9868747-B2
    优先权日:2014-02-18
    标题:Marinopyrrole derivatives and methods of making and using same
    发明人:LI RONGSHI; SEBTI SAID; LIU YAN; QIN YONG; SONG HAO; CHENG CHUNWEI
    权利人:H LEE MOFFITT CANCER CT & RES; CHONGQING ZEIN PHARMACEUTICAL CO LTD
    摘要:Marinopyrrole derivatives and methods for their synthesis and use are described herein. Novel cyclic and symmetric marinopyrroles with triazole substituents having antibacterial activity against resistant bacterial strains, such as MRSA are introduced. Also provided are methods of using the compounds for treating or preventing cancer and/or microbial infections.

    供应商参考报价(招募中)

    品牌试剂参考报价(招募中)

    📌 第三方产品分析报告

    ✅ COA系统入驻 | 共享模式

    主要参考文献


    1: Nam YH, Hwang EK, Ban GY, Jin HJ, Yoo HS, Shin YS, Ye YM, Nahm DH, Park HS, Lee SK. Immunologic evaluation of patients with cefotetan-induced anaphylaxis. Allergy Asthma Immunol Res. 2015 May;7(3):301-3. doi: 10.4168/aair.2015.7.3.301.
    2: Liu Y, Huang J, Liu J, Ma L, Lv Y, Shi S. A simple and sensitive liquid chromatographic technique for the determination of cefotetan disodium in human plasma and its application in a pharmacokinetic study. J Huazhong Univ Sci Technolog Med Sci. 2012 Oct;32(5):779-84. doi: 10.1007/s11596-012-1034-2. doi: 10.1007/s13318-011-0064-7. doi: 10.1016/j.clinthera.2010.09.015. doi: 10.3346/jkms.2010.25.3.429.
    6: Goldstein EJ, Citron DM, Merriam CV, Abramson MA. Infection after elective colorectal surgery: bacteriological analysis of failures in a randomized trial of cefotetan vs. ertapenem prophylaxis. Surg Infect (Larchmt). 2009 Apr;10(2):111-8. doi: 10.1089/sur.2007.096. doi: 10.1089/sur.2007.047. doi: 10.1089/sur.2007.034. Asian J Transfus Sci. 2008 Jan;2(1):20-3. doi: 10.4103/0973-6247.39507.

    合成参考文献


    摘要:Annals of Internal Medicine., 116(522), 1992
    摘要:Drugs in Japan, -(565), 1990
    📝 需求与反馈
    尽可能描述清楚需求与问题信息
    ×

    通知